Dr. Inocencio A. Cuesta

Dr. J. Michelle Kahlenberg MD, PhD is a physician scientist and Associate Professor of Internal Medicine at the University of Michigan. She completed her MD, PhD, and Internal Medicine training at Case Western Reserve University and completed her fellowship in Rheumatology at the University of Michigan. She joined the University of Michigan faculty in 2011, was appointed Assistant Professor in 2012, and was promoted to Associate Professor with tenure in 2018. She has been running her own laboratory and has been an active member of the Immunology Training Program since 2013. Her clinical work is centered on the care of complicated lupus patients, including those with refractory skin disease. Her R01-funded research laboratory combines translational approaches using patient samples and murine models to uncover the mechanisms that drive lupus and lupus flares. In particular, she is focused on unraveling the pathogenic mechanisms in cutaneous lupus, the factors that drive photosensitivity, and how skin inflammation can influence systemic lupus activity. Her work has received institutional accolades and national recognition from the Arthritis National Research Foundation, The Rheumatology Research Foundation, American Society for Clinical Investigation and the Lupus Foundation of America. In her spare time, she enjoys organic gardening, working on the family farm EMMA Acres run by her husband, Mark, and spending time with her husband and children. Dr. Kahlenberg is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus (SLE), Dermatomyositis, and Mevalonate Kinase Deficiency. Dr. Kahlenberg is board certified in Rheumatology. Dr. Kahlenberg is currently accepting new patients.

Dr. Fox is a graduate of the Massachusetts Institute of Technology and Harvard Medical School. Following internal medicine residency and rheumatology fellowship at the Brigham and Women's Hospital, he joined the faculty of the University of Michigan School of Medicine in 1985. Dr. Fox is Professor of Internal Medicine and, from 1990 to 2018, was Chief of the Division of Rheumatology. In addition, he co-directs the University of Michigan Clinical Autoimmunity Center of Excellence. In 2013, Dr. Fox became the Frederick G. L. Huetwell and William D. Robinson, M.D. Professor of Rheumatology. Dr. Foxs research focuses on defining and characterizing pathways of human T cell activation, determining the role of these pathways in the pathogenesis of autoimmune disease, investigating T cell interactions with synovial fibroblasts, understanding the role of interleukin-17 in arthritis, and exploring novel approaches to the treatment of rheumatoid arthritis and scleroderma. He is author of more than 230 scientific papers and book chapters and has served on the Editorial Board of Arthritis & Rheumatism, as an Associate Editor and Section Editor of the Journal of Immunology and as an Associate Editor of the Journal of Clinical Investigation. His published work has been cited more than 10,000 times. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. Dr. Fox is also active in the clinical care of patients with rheumatic diseases and in teaching students and fellows in both clinical and research settings. Dr. Fox has been an ACR ()American College of Rheumatology) member since 1985, an ACR volunteer since 1991, and an ACR Master since 2018. He has been a member of 12 ACR and RRF committees and task forces and chaired the Publications Committee, Finance Committee, and Monitoring Committee. In 2011-2012, Dr. Fox later co-chaired the ACR Task Force on Academic Rheumatology. From 2007-2008, Dr. Fox served as the seventy-first President of the American College of Rheumatology and the sixth ACR President from the University of Michigan. Dr. Fox currently holds leadership positions in the Immune Tolerance Network and in the Biomarkers Consortium of the Foundation for the NIH. Dr. Fox is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Scleroderma, Adult Still's Disease, Systemic Sclerosis (SSc), and Tissue Biopsy. Dr. Fox is currently accepting new patients.

John Varga is a Rheumatologist practicing medicine in Ann Arbor, Michigan. Dr. Varga is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Localized Scleroderma. Dr. Varga is board certified in Rheumatology and Internal Medicine. Dr. Varga is currently accepting new patients.